Renal Cancer
147
41
51
54
Key Insights
Highlights
Success Rate
78% trial completion
Published Results
28 trials with published results (19%)
Research Maturity
54 completed trials (37% of total)
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 59/100
10.2%
15 terminated out of 147 trials
78.3%
-8.3% vs benchmark
3%
5 trials in Phase 3/4
52%
28 of 54 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 54 completed trials
Clinical Trials (147)
Comprehensive Omics Analysis of Pediatric and Adult Solid Tumors and Establishment of a Repository for Related Biological Studies
Multiparametric MRI for Diagnosing Small Renal Tumors
Vaccination of Patients With Renal Cell Cancer With Dendritic Cell Tumor Fusions and GM-CSF
A Study of Several Radiation Doses for Patients With Progression on Immunotherapy/Checkpoint Inhibitors
SL-28 for Advanced Solid Tumours
A Phase 1 Clinical Study of NXP900 in Subjects With Advanced Cancers
Evaluate The Utility Of 124I-cG250 for The Early Detection Of Response to Therapy In Patients With Metastatic Renal Cell Carcinoma
Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer
Ablation of Renal Masses Outcomes Registry (ARMOR): Ablation Procedure and Quality of Life Assessment
Collection of Serum and Tissue Samples From Patients With Biopsy-Proved or Suspected Malignant Disease
The HistoSonics Edison™ System for Treatment of Primary Solid Renal Tumors Using Histotripsy (#HOPE4KIDNEY)
Research of Double-positive Circulating Cells (Tumor Marker / CD45+) in Several Types of Metastatic Cancers
Registry of Minimally Invasive Cancer Treatment Using Spectral Angio-CT Image Guidance
A Study of Autogene Cevumeran (RO7198457) as a Single Agent and in Combination With Atezolizumab in Participants With Locally Advanced or Metastatic Tumors
A Study Comparing Single-Port and Multi-Port Robot-Assisted Surgery in Patients With Prostate or Kidney (Renal) Cancer
Video Education With Result Dependent dIsclosure
CD70-targeted immunoPET Imaging of Malignant Cancers
Advanced Diffusion Imaging in Renal Cancer Patients
Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors
A Study Evaluating the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of AUR 109 in Patients With Colorectal, Ovarian, and Renal Cancers